Researchers analyzed two large genetic databases to look for predicted pathogenic variants in genes linked to autosomal dominant polycystic liver disease (ADPLD). This was a preclinical analysis of genetic data, not a study of people with the disease.
The analysis found that one predicted pathogenic variant occurs in about 1 in 95 people overall. Using a different method, the frequency was about 1 in 151 people. The frequency was higher in admixed American, Finnish, and African/African American populations compared to Europeans.
These findings are based on predicted variants, not confirmed disease cases. Many people with these variants may never develop symptoms because the disease does not always appear (incomplete penetrance).
The main reason to be careful is that this is a database analysis, not a clinical study. It shows genetic patterns but does not prove who will get sick. Readers should understand this is early, population-level data that does not change medical care.